Zeina Kais, PhD

Zeina Kais Ph.D. is postdoctoral fellow in the lab of Dr. Alan D’Andrea at Dana Farber Cancer institute in Boston, MA. Dr. Kais earned her B.S. and M.S. from the American University of Beirut (Beirut, Lebanon) and has recently completed her Ph.D. in Molecular Cellular and Developmental Biology under the guidance of Dr. Jeffrey Parvin at the Ohio State University (Columbus, OH). As a graduate student, she was awarded the Presidential Fellowship by the Ohio State University Graduate School in recognition of her outstanding scholarly accomplishments. During her graduate training, her research focused on studying the effect of the different modifiers of the breast/ovarian cancer associated gene 1 (BRCA1) on the function of the protein in the control of centrosome number and DNA damage repair: events that contribute to genetic instability and eventually carcinogenesis. Her current research interests include characterizing and generating pre-clinical data for small molecule inhibitors for the treatment of high grade serous carcinoma (HGSC) with amplified Cyclin E1, an aggressive subtype of ovarian cancer.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]